Otsuka Pharmaceutical Co. Newsletter
-
<![CDATA[4DMT and Otsuka Pharmaceutical partner on 4D-150 in the greater Asia-Pacific region]]>
09 Nov 2025 16:05 GMT
… ) announced a strategic partnership with Otsuka Pharmaceutical to develop and commercialize 4D … , president and representative director of Otsuka Pharmaceutical, commented on the partnership in …
-
4DMT Announces Exclusive License Agreement with Otsuka Pharmaceutical Co., Ltd. for Development and Commercialization of 4D-150 in Asia-Pacific
31 Oct 2025 03:02 GMT
… announced a strategic partnership with Otsuka Pharmaceutical Co., Ltd. (Otsuka) to develop … , President and Representative Director of Otsuka Pharmaceutical Co., Ltd. “By introducing 4D …
-
Ramaswamy-Backed Ambros Launches with $125M
22 Dec 2025 18:33 GMT
… billion sale to Japan-based Otsuka Pharmaceutical Co. in 2015.
Ambros, with …
-
Tuberculosis Therapeutics Market See Incredible Growth 2025-2032 | Otsuka Pharmaceutical Co., Ltd., Lupin Limited
10 Oct 2025 09:59 GMT
… This Report:
◘ Johnson and Johnson
◘ Otsuka Pharmaceutical Co., Ltd.,
◘ Lupin Limited
◘ Cipla …
-
SORT inhibitors described in Otsuka Pharmaceutical patent
08 Sep 2025 17:59 GMT
Neurology/psychiatric
Otsuka Pharmaceutical Co. Ltd. has identified new …
-
FDA grants accelerated approval to Voyxact in IgA nephropathy
19 Dec 2025 18:33 GMT
… press release.
Sibeprenlimab-szsi (Voyxact, Otsuka Pharmaceutical) is the first A-proliferation …
-
Schizophrenia Drugs Market Research Report 2025-2035, Competitive Analysis of Prominent Players - Novartis, Johnson & Johnson, Eli Lilly and Co, Otsuka Pharmaceutical, and Pfizer - ResearchAndMarkets.com
28 May 2025 19:29 GMT
… , Inc.
Eli Lilly and Company
Otsuka Pharmaceutical Co., Ltd.
Pfizer, Inc.
Key …
-
Otsuka Pharmaceutical discovers new CSF1R inhibitors
27 May 2025 20:06 GMT
Neurology/psychiatric
Otsuka Pharmaceutical Co. Ltd. has described macrophage …
-
NPPA fixes retail prices for Otsuka Pharmaceutical's 3 formulations
09 May 2025 20:46 GMT
… fixed the retail price of Otsuka Pharmaceutical's 3 scheduled … Authority had received applications from Otsuka Pharmaceutical India Private Limited for separate … deliberated upon the applications of Otsuka Pharmaceutical India Private Limited and approved …
-
<![CDATA[Impact of Medicaid Institution for Mental Diseases Exclusion on Serious Mental Illness Outcomes ]]>
18 Dec 2025 04:16 GMT
… York (OB), New York, NY; Otsuka Pharmaceutical Development & Commercialization, Inc (HCW … ), Cambridge, England.
Source of Funding: Otsuka Pharmaceutical Development and Commercialization, Inc.
Author …
About
© 1995-2025